The US National Institutes of Health (NIH) is still funding new experiments on cats despite announcing plans to phase out such projects. According to documents obtained by a watchdog group, the NIH has awarded over $1.7 million in new grants for experiments involving cats since July.
This move contradicts the NIH's claims that it opposes using cats in experiments and argues that the agency is "legally constrained" from ending projects. However, NIH policy states there is no legal obligation to provide funding beyond the end of the current budget period.
The funds were allocated for various research studies involving kittens, including one studying blood flow in the brain after a stroke, where 60 kittens will have their skulls removed and undergo viruses injections before being killed. Another study investigating gene therapy for human glaucoma received $439,000, with kittens bred to have glaucoma injected with viruses and then killed.
Critics say that this allocation of funds contradicts the NIH's claim about phasing out cat experiments and argue that the agency is misleading the public on its plans to reduce animal testing. The watchdog group White Coat Waste (WCW) calls for all existing grants for cat testing to be canceled, as well as prohibiting new ones.
Justin Goodman, WCW senior vice-president, believes that President Donald Trump should intervene in this matter and says that the NIH has been "doubling down" on funding experiments despite better alternatives existing. The issue is part of a growing trend towards reducing animal use in US laboratories.
This move contradicts the NIH's claims that it opposes using cats in experiments and argues that the agency is "legally constrained" from ending projects. However, NIH policy states there is no legal obligation to provide funding beyond the end of the current budget period.
The funds were allocated for various research studies involving kittens, including one studying blood flow in the brain after a stroke, where 60 kittens will have their skulls removed and undergo viruses injections before being killed. Another study investigating gene therapy for human glaucoma received $439,000, with kittens bred to have glaucoma injected with viruses and then killed.
Critics say that this allocation of funds contradicts the NIH's claim about phasing out cat experiments and argue that the agency is misleading the public on its plans to reduce animal testing. The watchdog group White Coat Waste (WCW) calls for all existing grants for cat testing to be canceled, as well as prohibiting new ones.
Justin Goodman, WCW senior vice-president, believes that President Donald Trump should intervene in this matter and says that the NIH has been "doubling down" on funding experiments despite better alternatives existing. The issue is part of a growing trend towards reducing animal use in US laboratories.